Please use this identifier to cite or link to this item: http://e.ieu.edu.ua/handle/123456789/1169
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMalyshev, Victor-
dc.contributor.authorGab, Angelina-
dc.contributor.authorKovalenko, Viktoriia-
dc.contributor.authorPryshedko, Oleksandr-
dc.contributor.authorShakhnin, Dmytro-
dc.date.accessioned2024-04-04T11:51:47Z-
dc.date.available2024-04-04T11:51:47Z-
dc.date.issued2024-02-29-
dc.identifier.citationTechnology audit and production reserves, 2024, № 4(75), p. 48-59uk
dc.identifier.issn2706-5448 (el.)-
dc.identifier.urihttp://e.ieu.edu.ua/handle/123456789/1169-
dc.description.abstractThe object of research is the state, segment analysis, dynamics, competition and prospects of the global nanomedicine market. The methods of searching and analyzing literary data, summarizing, systematizing and visualizing data using diagrams are used. In 2020, health care was identified as the most commercial sector of the modern nanotechnology market with a share of capital investments of 19.5 %. The leadership of this field is due to the increased use of nanotechnology in the development of nanodiagnostics, nanosurgical robots, applications for cell repair, nanobiosensors, visualization and targeted drug delivery. According to the analysis of the nanomedicine market, the structure of nanomaterials in 2022 was dominated by the segment of nanoparticles with a share of capital investments of 74 %, by the scope of application – the segment of drug delivery (25.1 %), by the method of action – the segment of treatment (23.8 %), by the scope of action – the segment of clinical oncology (32.4 %), by geographical regions – the segment of the North America region (26.4 %). The main factors of the dynamics of the global market of nanomedicine are determined. This is an increase in the prevalence of chronic diseases; modern achievements in the development of nanomaterials and nanotechnologies; limited possibilities of the nanomedicine market; significant costs for scientific research, development of drugs and devices. As well as concerns about the safety of using nanomaterials and nanotechnologies; the potential toxicity and long-term effects of nanoparticle exposure on human health are under investigation. Prospects for further scientific research in the field of nanomedicine are determined. This is the deepening of collaboration and cooperation of the world’s scientists and manufacturers of medical nanoproducts; development of new technologies for obtaining nanoparticles, especially composites of organic and inorganic origin; creation of medicinal forms for external, internal and inhalation use. As well as the search for new nanopreparations and studying the mechanisms of their therapeutic action; research of toxicological, kinetic and dynamic effects of nanomaterials; establishment of all aspects of the interaction of nanostructures with the body and the environment. And a significant increase in the volume of scientific research on nanomedicine and nanophysiotherapy; an increase in government funding for research and development, which will open up attractive opportunities for the expansion of the global nanomedicine market.uk
dc.language.isoenuk
dc.publisherTechnology audit and production reserves, 2024,uk
dc.relation.ispartofseries№ 4(75);-
dc.subjectnanomedicineuk
dc.subjectworld marketuk
dc.subjectmarket statusuk
dc.subjectsegment analysisuk
dc.subjectmarket dynamicsuk
dc.subjectcompetitionuk
dc.subjectmarket prospectsuk
dc.titleEstimation of global nanomedicine market: status, segment analysis, dynamics, competition and prospectsuk
dc.typeArticleuk
Appears in Collections:Кафедра фундаментальних та медико-профілактичних дисциплін

Files in This Item:
File Description SizeFormat 
1929042.pdf398.55 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.